Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Pierre Cosyns

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Journal of the American Society of Nephrology : JASN|October 25, 2001
Familial juvenile hyperuricemic nephropathy and autosomal dominant medullary cystic kidney disease type 2: two facets of the same disease?Karin Dahan, Arno Fuchshuber, Stavroula Adamis, et al.
European Journal of Anaesthesiology|September 28, 2011
Do intraoperative analgesics influence oncological outcomes after radical prostatectomy for prostate cancer?Patrice Forget, Bertrand Tombal, Jean-Louis Scholtès, et al.
Urology|February 9, 2002
Free/total PSA ratio does not improve prediction of pathologic stage and biochemical recurrence after radical prostatectomyBertrand Tombal, Michael Querton, Philippe de Nayer, et al.
Transplantation|October 13, 2015
Long-term Outcome of Kidney Recipients Transplanted for Aristolochic Acid NephropathyNada Kanaan, Ziad Hassoun, Claudia Raggi, et al.
European Journal of Clinical Investigation|February 5, 2013
Control of AA amyloidosis complicating Crohn's disease: a clinico-pathological studyMarie A Denis, Jean-Pierre Cosyns, Alexandre Persu, et al.
Kidney International|March 13, 2003
Altered polarity and expression of H+-ATPase without ultrastructural changes in kidneys of Dent's disease patientsPierre Moulin, Takashi Igarashi, Patrick Van der Smissen, et al.
Kidney International Reports|June 2, 2018
Genotype and Outcome After Kidney Transplantation in Alport SyndromeValentine Gillion, Karin Dahan, Jean-Pierre Cosyns, et al.
International Journal of Cancer|August 10, 2004
Aristolochic acid (AA)-DNA adduct as marker of AA exposure and risk factor for AA nephropathy-associated cancerVolker M Arlt, Véronique Alunni-Perret, Gérald Quatrehomme, et al.
Annals of Internal Medicine|April 5, 2013
The epidemiology, diagnosis, and management of aristolochic acid nephropathy: a narrative reviewM Refik Gökmen, Jean-Pierre Cosyns, Volker M Arlt, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 16, 2020
Podocyte Antigen Staining to Identify Distinct Phenotypes and Outcomes in Membranous Nephropathy: A Retrospective Multicenter Cohort StudyNicolas Hanset, Selda Aydin, Nathalie Demoulin, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Journal of the American Society of Nephrology : JASN|October 25, 2001
Familial juvenile hyperuricemic nephropathy and autosomal dominant medullary cystic kidney disease type 2: two facets of the same disease?Karin Dahan, Arno Fuchshuber, Stavroula Adamis, et al.
European Journal of Anaesthesiology|September 28, 2011
Do intraoperative analgesics influence oncological outcomes after radical prostatectomy for prostate cancer?Patrice Forget, Bertrand Tombal, Jean-Louis Scholtès, et al.
Urology|February 9, 2002
Free/total PSA ratio does not improve prediction of pathologic stage and biochemical recurrence after radical prostatectomyBertrand Tombal, Michael Querton, Philippe de Nayer, et al.
Transplantation|October 13, 2015
Long-term Outcome of Kidney Recipients Transplanted for Aristolochic Acid NephropathyNada Kanaan, Ziad Hassoun, Claudia Raggi, et al.
European Journal of Clinical Investigation|February 5, 2013
Control of AA amyloidosis complicating Crohn's disease: a clinico-pathological studyMarie A Denis, Jean-Pierre Cosyns, Alexandre Persu, et al.
Kidney International|March 13, 2003
Altered polarity and expression of H+-ATPase without ultrastructural changes in kidneys of Dent's disease patientsPierre Moulin, Takashi Igarashi, Patrick Van der Smissen, et al.
Kidney International Reports|June 2, 2018
Genotype and Outcome After Kidney Transplantation in Alport SyndromeValentine Gillion, Karin Dahan, Jean-Pierre Cosyns, et al.
International Journal of Cancer|August 10, 2004
Aristolochic acid (AA)-DNA adduct as marker of AA exposure and risk factor for AA nephropathy-associated cancerVolker M Arlt, Véronique Alunni-Perret, Gérald Quatrehomme, et al.
Annals of Internal Medicine|April 5, 2013
The epidemiology, diagnosis, and management of aristolochic acid nephropathy: a narrative reviewM Refik Gökmen, Jean-Pierre Cosyns, Volker M Arlt, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 16, 2020
Podocyte Antigen Staining to Identify Distinct Phenotypes and Outcomes in Membranous Nephropathy: A Retrospective Multicenter Cohort StudyNicolas Hanset, Selda Aydin, Nathalie Demoulin, et al.
Pageof 4